Sporeamicin A, a new macrolide antibiotic. III. Biological properties.

J Antibiot (Tokyo)

Research Laboratories, Toyo Jozo Co., Ltd., Shizuoka, Japan.

Published: May 1992

Sporeamicin A is a new erythromycin-type antibiotic isolated from a species of Saccharopolyspora. It was active in vitro against a wide variety of Gram-positive bacteria. In vitro studies indicated that the sporeamicin A was stable in the presence of human serum, although it was bound to serum proteins. Sporeamicin A was effective in the mouse protection test against Staphylococcus aureus, Streptococcus pyogenes and Streptococcus pneumoniae. Sporeamicin A attained higher plasma and tissue levels in the rat than did erythromycin stearate.

Download full-text PDF

Source
http://dx.doi.org/10.7164/antibiotics.45.613DOI Listing

Publication Analysis

Top Keywords

sporeamicin
5
sporeamicin macrolide
4
macrolide antibiotic
4
antibiotic iii
4
iii biological
4
biological properties
4
properties sporeamicin
4
sporeamicin erythromycin-type
4
erythromycin-type antibiotic
4
antibiotic isolated
4

Similar Publications

Sporeamicin A, a new macrolide antibiotic. III. Biological properties.

J Antibiot (Tokyo)

May 1992

Research Laboratories, Toyo Jozo Co., Ltd., Shizuoka, Japan.

Sporeamicin A is a new erythromycin-type antibiotic isolated from a species of Saccharopolyspora. It was active in vitro against a wide variety of Gram-positive bacteria. In vitro studies indicated that the sporeamicin A was stable in the presence of human serum, although it was bound to serum proteins.

View Article and Find Full Text PDF

Sporeamicin A, a new macrolide antibiotic. II. Structure determination.

J Antibiot (Tokyo)

May 1992

Research Laboratories, Toyo Jozo Co., Ltd., Shizuoka, Japan.

Structure of a novel antibiotic, sporeamicin A (SRM-A), was determined by a combination of spectroscopic and X-ray crystallographic studies. SRM-A has a unique structure containing a 2,3-dihydro-3-oxofuran moiety as part of a 14-membered macrolide ring.

View Article and Find Full Text PDF

Sporeamicin A, a novel antibiotic, was isolated from the culture filtrate of an actinomycete. The producing organism, strain L53-18, was taxonomically assigned as a species of the genus Saccaropolyspora. The antibiotic was extracted with chloroform and was then purified by crystallization.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!